Beaudoin Margaret 4
4 · Verve Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Beaudoin Margaret
Vice President, Finance
Transactions
- Purchase
Common Stock
2021-06-21$19.00/sh+1,000$19,000→ 1,000 total - Award
Stock Option (right to buy)
2021-06-17+10,799→ 10,799 totalExercise: $19.00Exp: 2031-06-16→ Common Stock (10,799 underlying)
Footnotes (1)
- [F1]The option was granted on June 17, 2021. 25% of the shares underlying the option will vest on June 1, 2022, and the remainder are scheduled to vest in equal monthly installments thereafter until June 1, 2025.